Beneficial ownership — 13D / 13G
87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Abdiel Qualified Master Fund, LP | APPN Appian Corp | 13D/A | 23.9% | Aug 22, 2024 | 2y |
| Atlas Investissement SAS | TIGO Millicom International Cellular SA | 13D/A | 40.42% | Aug 22, 2024 | 2y |
| Elliott Investment Management L.P. | LUV Southwest Airlines Co | 13D/A | 9.7% | Aug 22, 2024 | 2y |
| Blackstone Holdings II L.P. | GEL Genesis Energy LP | 13D/A | 8.1% | Aug 22, 2024 | 2y |
| Saba Capital Management, L.P. | NBXG Neuberger Next Generation Connectivity Fund Inc. | 13D/A | 7.42% | Aug 22, 2024 | 2y |
| Investissement Quebec | LDTCF LeddarTech Holdings Inc. | 13D/A | 14.82% | Aug 19, 2024 | 2y |
| Phillip Frost, M.D. | FLNT Fluent, Inc. | 13D/A | 22.5% | Aug 19, 2024 | 2y |
| Brown Ross Peter | DBGI Digital Brands Group, Inc. | 13D | 8.7% | Aug 19, 2024 | 2y |
| Daniel Wagner | RZLV Rezolve Ai PLC | 13D | 23.21% | Aug 15, 2024 | 2y |
| TCG Crossover GP II, LLC | AMLX Amylyx Pharmaceuticals, Inc. | 13G | 6.8% | Aug 14, 2024 | 2y |
| Mastrangeli Doug | AGRX Agile Therapeutics, Inc | 13G | 5.1% | Aug 6, 2024 | 2y |
| Strategic Value Partners, LLC | CBL Cbl & Associates Properties Inc | 13D/A | 9% | Aug 26, 2022 | 2y |
| OPKO HEALTH, INC. | WGS GeneDx Holdings Corp. | 13D/A | 9.29% | Aug 22, 2024 | 2y |
| Bhat Laxminarayan | RVPH Reviva Pharmaceuticals Holdings, Inc. | 13D/A | 8.6% | Aug 22, 2024 | 2y |
| HL Voting Trust | HLI Houlihan Lokey, Inc. | 13D/A | 24.1% | Aug 22, 2024 | 2y |
| Parag Saxena | RVPH Reviva Pharmaceuticals Holdings, Inc. | 13D/A | 16.9% | Aug 22, 2024 | 2y |
| TORONTO DOMINION BANK | SCHW Schwab Charles Corp | 13D/A | 7.6% | Aug 21, 2024 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | FULC Fulcrum Therapeutics, Inc. | 13G/A | 9.99% | Aug 21, 2024 | 2y |
| Q Power LLC | SDIG Stronghold Digital Mining, Inc. Class A Common Stock | 13D/A | 16.6% | Aug 21, 2024 | 2y |
| Beryl Capital Management LLC | SDIG Stronghold Digital Mining, Inc. Class A Common Stock | 13G | 9.9% | Aug 21, 2024 | 2y |
| BASS CHARLIE | SCKT Socket Mobile, Inc. | 13D/A | 35.5% | Aug 21, 2024 | 2y |
| THOMPSON DAVIS & CO., INC. | ESOA Energy Services of America CORP | 13G/A | 1.71% | Aug 19, 2024 | 2y |
| EcoR1 Capital, LLC | LKFT Lakefront Biotherapeutics NV | 13D | 9.9% | Aug 19, 2024 | 2y |
| MILLENNIUM MANAGEMENT LLC | OM Outset Medical, Inc. | 13G | 5.5% | Aug 19, 2024 | 2y |
| Conlin Matthew | FLNT Fluent, Inc. | 13D/A | 13.6% | Aug 19, 2024 | 2y |
| Schulke Ryan | FLNT Fluent, Inc. | 13D/A | 21.52% | Aug 19, 2024 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | AVTX Avalo Therapeutics, Inc. | 13G | 9.99% | Aug 13, 2024 | 2y |
| Formation8 Partners Fund I, L.P. | BSLK Bolt Projects Holdings, Inc. | 13G | 5.2% | Aug 13, 2024 | 2y |
| Top Tier Capital Partners, LLC | BSLK Bolt Projects Holdings, Inc. | 13G | 7.9% | Aug 13, 2024 | 2y |
| Temasek Holdings (Private) Ltd | BSLK Bolt Projects Holdings, Inc. | 13G | 7.8% | Aug 13, 2024 | 2y |
| Foundation Capital Management Co. VI, L.L.C. | BSLK Bolt Projects Holdings, Inc. | 13G | 7.3% | Aug 13, 2024 | 2y |
| Patrick J. Crutcher | AVTX Avalo Therapeutics, Inc. | 13G | 9.9% | Aug 13, 2024 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | AVTX Avalo Therapeutics, Inc. | 13G | 9.99% | Aug 13, 2024 | 2y |
| Braden Ferrari | BTLN Brightline Interactive, Inc. | 13G/A | 6% | Aug 8, 2024 | 2y |
| GK Partners ApS | NORD Nordicus Partners Corp | 13D/A | 45.2% | May 14, 2024 | 2y |
| Nippon Shinyaku Co., Ltd. | CAPR Capricor Therapeutics, Inc. | 13G/A | 13.2% | Apr 3, 2024 | 2y |
| Grupo Angeles Servicios de Salud, S.A. de C.V. | AUNA Auna S.A. | 13D | 20.46% | Aug 22, 2024 | 2y |
| Galkin Vladimir | JBLU Jetblue Airways Corp | 13G/A | 9.1% | Aug 22, 2024 | 2y |
| Blue Star Exploration Company | CRK Comstock Resources Inc | 13D/A | 70.7% | Aug 22, 2024 | 2y |
| John P. Stupp, Jr. | ATRI Atrion Corp | 13D/A | 0% | Aug 21, 2024 | 2y |
| Stupp Bros., Inc. | ATRI Atrion Corp | 13D/A | 0% | Aug 21, 2024 | 2y |
| Emile A Battat | ATRI Atrion Corp | 13D/A | 0% | Aug 21, 2024 | 2y |
| AGGIA FZ LLC | SDOT Sadot Group Inc. | 13D/A | 12.3% | Aug 21, 2024 | 2y |
| BAKER BROS. ADVISORS LP | KYMR Kymera Therapeutics, Inc. | 13D/A | 9.3% | Aug 21, 2024 | 2y |
| David A. Battat | ATRI Atrion Corp | 13D/A | 0% | Aug 21, 2024 | 2y |
| James N. Topper | PHAT Phathom Pharmaceuticals, Inc. | 13D/A | 18% | Aug 20, 2024 | 2y |
| Steven Huffman | RDDT Reddit, Inc. | 13D/A | 41% | Aug 20, 2024 | 2y |
| Kahn Roger E. | BLIN Bridgeline Digital, Inc. | 13D/A | 15.4% | Aug 20, 2024 | 2y |
| Elliott Investment Management L.P. | SDRL SEADRILL Ltd | 13D/A | 5.4% | Aug 20, 2024 | 2y |
| Trilogy Equity Partners, LLC | OWLT Owlet, Inc. | 13D/A | 18.7% | Aug 20, 2024 | 2y |